Clinical Trial Update: Efficacy and Tolerability of Tadalafil Versus Darifenacin in Management of Ureteric Stent-Related LUTS [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 study comparing tadalafil with darifenacin for management of ureteric stent-related lower urinary tract symptoms and pain, with completion reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Urinary Tract Symptoms

Drugs mentioned

• Darifenacin (darifenacin)
• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Ain Shams University | Conditions: Management of Ureteric Stent Related LUTS and Pain | Phase 1, Phase 2 | Status: COMPLETED